<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the underlying neuroprotective mechanisms of Tanshinone II A (TSA) on rat <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Study of TSA on rat <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vivo: Male SD rats were divided into four groups (sham-operated, ischemic and treated group (lower dose and higher dose) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> cerebral ischemmia after permanent bilateral carotid artery ligation was introduced as an in vivo ischemic model </plain></SENT>
<SENT sid="3" pm="."><plain>After <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> impairment, TSA (2, 4 mg x kg(-1) x d(-1)) was administrated by ip for 30 days in treated group </plain></SENT>
<SENT sid="4" pm="."><plain>We used <z:mp ids='MP_0001465'>Morris water maze</z:mp> to investigate the learning and memory </plain></SENT>
<SENT sid="5" pm="."><plain>Levels of malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), activity of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismetase (SOD) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GPX) in brain tissue were detected by spectrophotometer </plain></SENT>
<SENT sid="6" pm="."><plain>High-performance liquid chromatography (HPLC) with fluorescence detection was applied to measure the contents of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) in cortex and hippocampus </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: TSA can improve learning and <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>An elevation of SOD and GPX activity and decrease of <z:chebi fb="14" ids="32506">MDA</z:chebi> level were shown in TSA treated group after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Decreased <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> induced by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> were markedly inhibited by TSA pretreatment </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The neuroprotective effect of TSA are partly due to its functions as follow: anti-free radical injury; regulating the content of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> </plain></SENT>
</text></document>